Spots Global Cancer Trial Database for previously untreated childhood rhabdomyosarcoma
Every month we try and update this database with for previously untreated childhood rhabdomyosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma | NCT01626170 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - | Children's Oncology Group | |
| Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma | NCT01626170 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - | Children's Oncology Group | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
| Cryosurgery in Treating Patients With Soft Tissue Sarcoma | NCT00002863 | Sarcoma | chemotherapy conventional su... cryosurgery | - | University of Southern California | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00002995 | Sarcoma | dactinomycin filgrastim sargramostim cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma | NCT01342783 | Sarcoma | DNA analysis RNA analysis mutation analys... nucleic acid se... laboratory biom... | - 18 Years | Children's Oncology Group | |
| Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma | NCT01609803 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00002995 | Sarcoma | dactinomycin filgrastim sargramostim cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | NCT00379457 | Sarcoma | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide topotecan hydro... vincristine sul... vinorelbine tar... conventional su... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma | NCT00245141 | Sarcoma | dactinomycin cyclophosphamid... vincristine sul... radiation thera... | - 17 Years | National Cancer Institute (NCI) | |
| Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma | NCT00245089 | Sarcoma | dactinomycin cyclophosphamid... vincristine sul... | - 17 Years | National Cancer Institute (NCI) | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Protein Expression in Samples From Young Patients With Rhabdomyosarcoma | NCT01426945 | Sarcoma | protein express... immunohistochem... laboratory biom... | - | Children's Oncology Group | |
| Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma | NCT01609803 | Alveolar Childh... Embryonal Child... Previously Trea... Previously Untr... Recurrent Child... | laboratory biom... | - 21 Years | Children's Oncology Group | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor | NCT00003273 | Brain and Centr... Neuroblastoma Retinoblastoma Sarcoma | filgrastim carboplatin cisplatin cyclophosphamid... etoposide leucovorin calc... methotrexate temozolomide thiotepa vincristine sul... autologous bone... peripheral bloo... radiation thera... | - 10 Years | NYU Langone Health | |
| Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma | NCT00245141 | Sarcoma | dactinomycin cyclophosphamid... vincristine sul... radiation thera... | - 17 Years | National Cancer Institute (NCI) | |
| Cryosurgery in Treating Patients With Soft Tissue Sarcoma | NCT00002863 | Sarcoma | chemotherapy conventional su... cryosurgery | - | University of Southern California | |
| Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma | NCT00245089 | Sarcoma | dactinomycin cyclophosphamid... vincristine sul... | - 17 Years | National Cancer Institute (NCI) | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
| Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma | NCT00077285 | Sarcoma | filgrastim carboplatin cyclophosphamid... dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... | - 50 Years | Memorial Sloan Kettering Cancer Center | |
| Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma | NCT00075582 | Adult Rhabdomyo... Embryonal Child... Embryonal-botry... Previously Untr... | conventional su... dactinomycin cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma | NCT00003958 | Adult Malignant... Adult Rhabdomyo... Alveolar Childh... Childhood Malig... Embryonal Child... Embryonal-botry... Nonmetastatic C... Previously Untr... Stage I Adult S... Stage II Adult ... Stage III Adult... | dactinomycin vincristine sul... cyclophosphamid... therapeutic con... radiation thera... topotecan hydro... filgrastim sargramostim laboratory biom... | - 49 Years | Children's Oncology Group | |
| DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma | NCT01419509 | Sarcoma | DNA methylation... microarray anal... polymerase chai... laboratory biom... | - 18 Years | Children's Oncology Group | |
| High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | NCT00354744 | Sarcoma | dactinomycin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... filgrastim | - 49 Years | Children's Oncology Group | |
| High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | NCT00354744 | Sarcoma | dactinomycin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... filgrastim | - 49 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
